Frost-Pineda K et al. |
Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. |
2011 |
Nicotine Tob. Res. |
pmid:21330277
|
Varma D et al. |
Comparison of UHPLC and HPLC methods for the assay of prostanoids: "are the methods equivalent in terms of accuracy and precision?". |
2011 |
Bioanalysis |
pmid:21510759
|
Spectre G et al. |
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. |
2011 |
Thromb. Haemost. |
pmid:21800009
|
Gao F et al. |
Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease. |
2011 |
Chin. Med. J. |
pmid:21740787
|
Lessiani G et al. |
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. |
2011 |
Thromb. Haemost. |
pmid:21103664
|
Lynch CM et al. |
The role of thromboxane A(2) in the pathogenesis of intrauterine growth restriction associated with maternal smoking in pregnancy. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21723954
|
Di Minno MN et al. |
Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. |
2011 |
Thromb. Res. |
pmid:21669453
|
Halawani SH et al. |
Aspirin failure in patients presenting with acute cerebrovascular ischaemia. |
2011 |
Thromb. Haemost. |
pmid:21544317
|
Simeoni S et al. |
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects. |
2011 |
Stress |
pmid:21434833
|
Gremmel T et al. |
Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation. |
2011 |
Platelets |
pmid:21231857
|
Dragani A et al. |
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. |
2010 |
Blood |
pmid:19887674
|
Montine TJ et al. |
Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. |
2010 |
PLoS ONE |
pmid:20174466
|
Dharmasaroja PA and Sae-Lim S |
Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers. |
2010 |
Blood Coagul. Fibrinolysis |
pmid:20689403
|
Yassine HN et al. |
Clinical determinants of aspirin resistance in diabetes. |
2010 |
Diabetes Res. Clin. Pract. |
pmid:20719400
|
Warner JH et al. |
Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers. |
2010 |
BMC Med Res Methodol |
pmid:20233412
|
Fukushima H et al. |
Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin. |
2010 |
Am. J. Med. Genet. A |
pmid:20583254
|
Frisbee JC et al. |
Aspirin resistance with genetic dyslipidemia: contribution of vascular thromboxane generation. |
2010 |
Physiol. Genomics |
pmid:20530721
|
Antonino MJ et al. |
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. |
2010 |
Thromb. Res. |
pmid:19446864
|
Santilli F et al. |
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. |
2010 |
J. Thromb. Haemost. |
pmid:20088941
|
Addad F et al. |
Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease. |
2010 |
J. Thromb. Thrombolysis |
pmid:19381450
|